MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.8803 +0.0287 (+3.37%)
Streaming Delayed Price Updated: 12:41 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,276
Open 0.8550
Bid (Size) 0.8802 (1,000)
Ask (Size) 0.8890 (200)
Prev. Close 0.8516
Today's Range 0.8550 - 0.8851
52wk Range 0.8200 - 18.90
Shares Outstanding 4,168,223
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Regains NYSE Compliance, Advances Toward First Clinical Trial and Expands AI-Driven Neurology Pipeline
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Oragenics Q3 2025 Shareholder Update
From Oragenics, Inc.
Via Business Wire

Performance

YTD
-91.8%
-91.8%
1 Month
-22.1%
-22.1%
3 Month
-17.0%
-17.0%
6 Month
-75.1%
-75.1%
1 Year
-90.8%
-90.8%

More News

Read More
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Regains NYSE Compliance, Strengthens Balance Sheet for Clinical Advancement
Via Investor Brand Network
News headline image
Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
From Oragenics, Inc.
Via Business Wire
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Partners with Receptor.AI to Accelerate AI-Driven Discovery of Brain-Targeted Therapeutics
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development
From Oragenics
Via Business Wire
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Highlights Q2 2025 Progress and Prepares for Phase IIa Concussion Trial
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Selects Southern Star Research as CRO for Phase IIa Trial of Intranasal Concussion Therapy ONP-002
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Secures U.S. Manufacturing Partner Ahead of Phase IIb Trials for Concussion Drug
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Monday's after hours session: top gainers and losers ↗
Via Chartmill
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Secures $16.5 Million in Preferred Stock Offering to Advance Intranasal Concussion Therapy
Via Investor Brand Network
News headline image
Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Which stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
Nasdaq Dips 150 Points; US ISM Manufacturing PMI Rises In June ↗
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Tuesday? ↗
Via Chartmill
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Announces $20 Million Preferred Stock and Warrant Offering
Via Investor Brand Network
News headline image
US Stocks Mixed; Dow Gains Over 50 Points ↗
Via Benzinga
Topics Stocks
News headline image
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga

Frequently Asked Questions

Is Oragenics Inc. Common Stock publicly traded?
Yes, Oragenics Inc. Common Stock is publicly traded.
What exchange does Oragenics Inc. Common Stock trade on?
Oragenics Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Oragenics Inc. Common Stock?
The ticker symbol for Oragenics Inc. Common Stock is OGEN on the New York Stock Exchange
What is the current price of Oragenics Inc. Common Stock?
The current price of Oragenics Inc. Common Stock is 0.8803
When was Oragenics Inc. Common Stock last traded?
The last trade of Oragenics Inc. Common Stock was at 12/05/25 12:41 PM ET
What is the market capitalization of Oragenics Inc. Common Stock?
The market capitalization of Oragenics Inc. Common Stock is 3.67M
How many shares of Oragenics Inc. Common Stock are outstanding?
Oragenics Inc. Common Stock has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story